(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.18%) $79.09
(-0.64%) $2.02
(0.03%) $2 310.30
(0.17%) $26.88
(0.35%) $966.00
(-0.07%) $0.932
(-0.14%) $10.98
(-0.14%) $0.797
(1.50%) $92.50
-6.68% $ 0.0748
Live Chart Being Loaded With Signals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally...
Stats | |
---|---|
Volumen de hoy | 6 059.00 |
Volumen promedio | 28 581.00 |
Capitalización de mercado | 778 326 |
EPS | $0 ( 2024-03-29 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.112 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-22 | Baker Bros. Advisors Lp | Sell | 1 941 607 | Warrants (right to buy) |
2023-11-22 | Baker Bros. Advisors Lp | Buy | 1 941 607 | Common Stock |
2023-11-22 | Baker Bros. Advisors Lp | Sell | 174 742 | Warrants (right to buy) |
2023-11-22 | Baker Bros. Advisors Lp | Buy | 174 742 | Common Stock |
2023-05-05 | Baker Bros. Advisors Lp | Buy | 0 | Common Stock |
INSIDER POWER |
---|
9.33 |
Last 91 transactions |
Buy: 8 287 527 | Sell: 2 332 728 |
Bellicum Pharmaceuticals Correlación
10 Correlaciones Más Positivas | |
---|---|
CNDT | 0.957 |
FOSL | 0.943 |
VTRS | 0.932 |
TBNK | 0.928 |
SRTS | 0.927 |
RPAY | 0.925 |
FNWB | 0.923 |
GTEC | 0.922 |
LPCN | 0.919 |
GRPN | 0.918 |
10 Correlaciones Más Negativas | |
---|---|
TYHT | -0.933 |
NRDS | -0.905 |
BLCT | -0.897 |
CNST | -0.889 |
EPZM | -0.888 |
CNCE | -0.878 |
FLXN | -0.874 |
XOG | -0.872 |
AMRB | -0.869 |
HUGE | -0.86 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bellicum Pharmaceuticals Finanzas
Annual | 2022 |
Ingresos: | $1.50M |
Beneficio Bruto: | $1.50M (100.00 %) |
EPS: | $-0.810 |
FY | 2022 |
Ingresos: | $1.50M |
Beneficio Bruto: | $1.50M (100.00 %) |
EPS: | $-0.810 |
FY | 2021 |
Ingresos: | $6 200.00 |
Beneficio Bruto: | $6 200.00 (100.00 %) |
EPS: | $-0.000844 |
FY | 2020 |
Ingresos: | $500.00 |
Beneficio Bruto: | $500.00 (100.00 %) |
EPS: | $-0.00134 |
Financial Reports:
No articles found.
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. Its clinical product candidates also include Rivo-cel, an allogeneic T cell product candidate intended to enhance outcomes in the treatment of leukemias, lymphomas, and inherited blood disorders. It has collaboration and license agreements with Adaptimmune Therapeutics plc; Agensys, Inc.; BioVec Pharma, Inc.; ARIAD Pharmaceuticals, Inc.; and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico